InvestorsHub Logo
Followers 14
Posts 817
Boards Moderated 0
Alias Born 02/24/2010

Re: None

Friday, 09/05/2014 6:35:09 PM

Friday, September 05, 2014 6:35:09 PM

Post# of 403754
Leo has stated he was looking to partner B in other indications because they would be expensive to do so on their own. Toss in a meeting with big pharma, 30 kg B manufactured, resolution of a long-term grievance, and the upcoming significant corporate development. Perhaps we partnered B minus ABSSSI but the other indications for B and other parts of the old poly pipeline: oral mucositis, and antibacterial and antifungal infections.

With funds from this partner perhaps they take B ABSSSI to phase 3 on their own or its just another partnership in the making.

Feels like something is different here now..Exciting times!